SELECTA BIOSCIENCES INC | Human Resources | Business Contracts

Employment Agreement, dated as of November 9, 2022, by and between the Registrant and Blaine Davis (Filed With SEC on March 2, 2023)

Non-Employee Director Compensation Program (Filed With SEC on March 2, 2023)

Separation and Release Agreement, dated November 23, 2022, by and between the Registrant and Kevin Tan (Filed With SEC on March 2, 2023)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Stephen Smolinski (Filed With SEC on June 25, 2020)

Amendment to Consulting Agreement, dated December 31, 2018, to Consulting Agreement by and between Registrant and Omid Farokzhad, dated May 30, 2018 (Filed With SEC on March 15, 2019)

Non-Employee Director Compensation Program (Filed With SEC on November 9, 2021)

Employment Agreement, dated September 3, 2021, by and between Selecta Biosciences, Inc. and Kevin Tan (Filed With SEC on November 9, 2021)

Non-Employee Director Compensation Program (Filed With SEC on May 13, 2021)

Employment Agreement, dated July 31, 2020, by and between Selecta Biosciences, Inc. and Peter G. Traber, M.D (Filed With SEC on November 5, 2020)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Elona Kogan (Filed With SEC on June 25, 2020)

Non-Employee Director Compensation Program (Filed With SEC on May 7, 2020)

Employment Agreement, dated August 12, 2019, by and between Selecta Biosciences, Inc. and Bradford D. Dahms (Filed With SEC on November 8, 2019)

Employment Agreement, dated June 21, 2019, by and between Selecta Biosciences, Inc. and Alison Schecter, M.D (Filed With SEC on August 8, 2019)

Employment Agreement, dated March 19, 2019, between Selecta Biosciences, Inc. and Elona Kogan (Filed With SEC on May 9, 2019)

Employment Offer Letter, dated July 29, 2016, between Selecta Biosciences, Inc. and Ann K. Donohue, and Promotion Letter dated November 30, 2017 (Filed With SEC on May 9, 2019)

Transition Agreement and Release, dated March 6, 2019, between Selecta Biosciences, Inc. and John Leaman, M.D (Filed With SEC on March 8, 2019)

SELECTA BIOSCIENCES INC (47) | Human Resources (16)